US Patent 11072658 Anti-PD-1/LAG3 bispecific antibodies
All edits
Edits on 23 Oct, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 12 Dec, 2023
Golden AI
Edits made to:
Article (+242 characters)
Article
Patent abstract
Provided herein are anti-PD-1/LAG3 bispecific antibodies and antigen-binding fragments. Also provided here are methods and uses of these antibodies and antigen-binding fragments in the treatment of cancer or infectious disease.
Edits on 21 Jul, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 27 Apr, 2023
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
110726580
Date of Patent
July 27, 2021
0Patent Application Number
162642010
Date Filed
January 31, 2019
0Official Website
Patent Primary Examiner
Edits on 22 Mar, 2023
Golden AI
Infobox
Edits on 25 Sep, 2022
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
110726580
Date of Patent
July 27, 2021
0Patent Application Number
162642010
Date Filed
January 31, 2019
0Official Website
Patent Primary Examiner
Edits on 6 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 13 Feb, 2022
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 11072658 Anti-PD-1/LAG3 bispecific antibodies
Infobox
Is a
Patent jurisdiction
Patent number
11072658
Date of patent
July 27, 2021
Patent application number
16264201
Date Filed
January 31, 2019
Patent primary examiner
Find more entities like US Patent 11072658 Anti-PD-1/LAG3 bispecific antibodies
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
